Completed
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
NCT02718820
- Conditions
- Head and Neck Carcinoma
- Locations
-
- Medical University of Vienna Vienna, Austria